
ABT vs PCRX
$ABT vs $PCRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ABT vs PCRX: trend, levels and the market
One year to 2026-11-16, against the S&P 500 (+10.7%). Split-adjusted daily closes.
- ·Both are in uptrends, trading above their 50- and 200-day averages, so this compares two names the market is already bidding up.
- ·Only PCRX beat the market over the past year, by 46.9%, while ABT trailed the S&P 500 at +10.7% by 26.2%.
- ·The last month has flipped the order: ABT leads over the month (+2.4% against +0.4%) even though PCRX leads over the year.
- ·PCRX sits closer to its support, 0.1% above it at $36.43, while ABT is 5.2% above its own at $97.67.
- ·ABT is within 0.8% of resistance at $103.80, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
ABT vs PCRX: the quick read
- ·ABT is the larger company by market cap ($178.39B vs $1.46B).
- ·ABT has been more active on our scanner (84 vs 1 alerts in 30 days).
- ·PCRX has the smaller float (37.1M vs 1.72B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·ABT draws far more of our scanner's attention, 84 unusual-volume alerts in 30 days against 1, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: ABT is more than 122x the market cap of PCRX, so the same dollar of news moves PCRX far harder.
- ·ABT pays a dividend and PCRX does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching ABT or PCRX? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ABT and PCRX on TheDesperateTrader.
- Is ABT or PCRX the better stock?
- "Better" depends on your goal, and these two are not alike. ABT is the larger company by market cap ($178.39B vs $1.46B). ABT has been more active on our scanner (84 vs 1 alerts in 30 days). PCRX has the smaller float (37.1M vs 1.72B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ABT and PCRX?
- The differences that matter: ABT is roughly 122x the size of the other by market cap ($178.39B vs $1.46B); they trade at very different share prices ($103.00 vs $36.48); ABT sits at 44% of its 52-week range against 99% for PCRX; only ABT pays a dividend; our scanner flagged ABT 84 times in the last 30 days against 1 for PCRX. Everything above is measured from the latest completed session and SEC filings.
- Which of ABT and PCRX is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is ABT or PCRX in the stronger trend?
- ABT is above its 50-day average of $103.89 and above its 200-day average of $101.55; PCRX is above its 50-day average of $31.39 and above its 200-day average of $25.73. PCRX leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ABT or PCRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.